The Cooper Companies, Inc. stands out in the medical instruments and supplies industry with a solid performance in contact lenses and health care products. The stock has demonstrated consistent potential with unique product offerings in both CooperVision and CooperSurgical segments. Investors may find its diversified portfolio appealing for long-term growth.
The Cooper Companies, Inc. has achieved a B+ rating, reflecting a balanced approach to growth and stability.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 3 | |
| Return on Assets | 5 | |
| Debt to Equity | 2 | |
| Price to Earnings | 1 | |
| Price to Book | 3 |
Recent historical data shows consistency in scores, indicating stable performance over time.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-11-21 | 3 | 4 | 3 | 5 | 2 | 1 | 3 |
| Previous | 0 | 4 | 3 | 5 | 2 | 1 | 3 |
Analysts indicate a strong growth potential for COO with a median target price of $85 and a consensus rating of 'Buy'.
| High | Low | Median | Consensus |
|---|---|---|---|
| $100 | $64 | $85 | $84.14 |
The sentiment among analysts is predominantly positive, supporting a 'Buy' recommendation.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 14 | |
| Hold | 8 | |
| Sell | 1 | |
| Strong Sell | 0 |
The Cooper Companies, Inc. presents a promising investment opportunity due to its robust product lines in both the optical and healthcare sectors. With a stable historical performance and a positive buy recommendation from analysts, the stock appears to be a good medium to long-term investment. However, investors should consider potential risks, such as market volatility or changes in healthcare regulations, which could impact performance. Nonetheless, COO's diversified portfolio and strong market presence underscore its ability to navigate industry challenges effectively.